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The cellular functions necessary to sustain life are, in large part, mediated by the 
collection of translated proteins unique to each organism, referred to as the proteome. 
Due to the broad and ever-growing number of connections drawn between the proteome 
and biologically significant occurrences, proteomics has established itself as a critical 
field of research. Though the vastness of the proteome may be understood when assuming 
a single product for every translated gene, the complexity grows exponentially when 
considering the process of post-translational modification inherent for each protein and 
organism. As post-translational modifications are noted to be crucial in understanding the 
basic and altered functional states of all proteins, a large emphasis is placed on their 
identification and characterization. And though all post-translational modifications may 
be considered intricate, none is more so than glycosylation.  
Glycosylation stands preeminent in diversity and functionality when compared to 
other post-translational modifications. Owing to the fact that such modifications can exist 
in multiple structures, may incorporate several unique monosaccharide units, and are 
highly dependent on the enzymatic processes by which they are constructed, 
glycosylation modifications require careful consideration when one attempts to perform 
analysis and characterization of any glycoprotein conjugate. Knowing this, the following 
work should serve to provide context as to the elaborate nature of glycobiology, 
discussion of possible proteomic workflows useful for glycoprotein analysis, and 
understanding of gas-phase separation techniques. Such comprehensions are necessary 












Chapter 1: Glycobiology 
1.1 Introduction 
At the time of conception, the central dogma of biology was an accepted model 
for understanding how genetic information correlated to the proteins necessary for 
cellular growth, communication, and function. Slowly, the central dogma evolved as 
comprehension of biology grew, considering reverse-transcription, gene-peptide 
relationships, and various other biological revelations. As scientific endeavors pushed 
forward, and the disciplines of genomics, transcriptomics, metabolomics and others 
gained recognition, the central dogma became an oversimplification of the reality 
occurring between the formation of DNA and its translation into functional proteins. 
Regardless of what genes are present, and the level to which they may be expressed within 
an organism, the critical intermediate between genetic information and cellular function 
is the proteome. Referring to the collection of all proteins expressed within an organism, 
the expansive nature of the proteome is only truly recognized when accounting for the 
number of proteins expressed, the varying number of protein replicates, and the uniquely 
identified proteins that differ only by the post-translational modifications contained 
therein. Post-translational modifications, much like the proteins on which they may be 
deposited, are diverse in type, abundance, and functionality, making the accurate 
discussion of such a broad substituent class far outside the scope of this thesis. However, 
one post-translational modification (PTM) that stands out among the rest due to its 
unrivaled diversity, complexity, and implications in biological function, is glycosylation 




modification are quite extensive and accurate introduction must be given to foster 
understanding and appreciation of the later study.  
1.1.1 Structural Diversity in Glycosylation 
The glycosylation of a protein involves the enzymatically controlled transfer of 
oligosaccharide moieties to the peptide backbone of proteins. These oligosaccharide 
moieties – referred to throughout as “glycans” – are composed of repeating cyclic 
monosaccharide motifs, linked together by glycosidic bonds.1 As ring formations of these 
carbohydrate entities are produced, a chiral anomeric center is formed; this chiral center, 
or anomeric carbon, resides in the C-1 position for aldo- sugars and C-2 for keto- sugars1 
(figure 1.1). The glycosidic bonds that join monosaccharides involve a water-loss step as 
the hydroxyl group of the anomeric carbon leaves to make way for a new bond between 
the anomeric carbon and a hydroxyl-group oxygen of another monosaccharide ring. As 
cyclic monosaccharides have hydroxyl groups available on most, if not all, carbon 
centers, glycosidic bonds are named according to the carbons on each ring that terminate 
the newly-formed connection (e.g. 1-3, 1-4, 1-6, etc.) (figure 1.2). And since glycosidic 
bond formation is not restricted by stereochemistry, glycosidic bonds are further 
distinguished according to the identical or opposite orientation (i.e. axial or equatorial 
position) of the hydroxyl groups attached to the anomeric carbon and the stereocenter 
furthest in distance from the chiral center – α linkage referring to identical 
stereochemistry and β referring to the opposite (figure 1.2). Glycans are made more 
complex by the fact that multiple types of sugar residues exist in biology, all of which 




glycan chains typically reside within one of six classes: pentoses, hexoses, hexosamines, 
6-deoxyhexoses,  uronic acids, and nonulosonic acids (figure 1.3) – hexoses and 
hexosamines being of immediate relevance to the following work.(4.1) And within these 
six classes, there are shown to be more than seventy unique monosaccharides in total – 
though only twelve are considered commonly occurring1 – representing the extreme 
diversity that can arise when examining possible residue combinations. 
Complicating matters even more is the consideration of how these sugar chain 
moieties are attached to their conjugate substrate. Briefly, glycoconjugates exist in three 
distinct classes: glycosylphosphatidylinositol – which serves as the lipid anchor for many 
cell-surface proteins,2 glycosphingolipids and glycosaminoglycans – important for 
signaling pathways and membrane structure,3 and glycoproteins. The latter class of 
proteins as a conjugate species is one of breadth and complexity that cannot be easily 
summarized but may be slightly simplified due to the overwhelming abundance of certain 
binding sites compared to others. When referring to glycoproteins, glycan moieties are 
divided between the classically referenced O- and N-linked glycans. These groups denote 
the element – oxygen or nitrogen – with which a glycan moiety forms a glycosidic bond 
and, therefore, also provide assignment with which amino acid residues glycosidic 
linkages may be formed – an important distinction that is discussed later in detail. (1.3.2) 
The variations in glycan structure discussed so far – glycosidic bond location, α/β 
orientation, and constituent residues – begin to reveal the truly complex nature of glycan 
moieties and attempting to simultaneously evaluate the staggering number of proteins to 




comprehension. This inherent diversity of glycan-conjugate complexes brings with it 
terminology useful for referring to structural or compositional differences.  
1.1.2 Glycoform Distinction 
 Glycosylation, like all post-translational modifications, is an enzymatically 
controlled process. The nature of enzymes responsible for glycan construction and 
deposition will be discussed, (1.3.2) but since variable enzymatic activity is a common 
biological occurrence, it is easy to imagine the variation of glycoprotein species due to 
slight inconsistencies in enzyme behavior. Since the enzymes involved in glycosylation 
– transferases and glycosidases – are highly specific in their function and will all 
constitutively attempt to perform their various processes, it may be reasonably understood 
that a collection of multiple localized enzymes could not only create multiple copies of 
the same glycan moiety and glycoprotein product but can also produce glycan moieties 
unique in structure and composition. These unique moieties – that can differ by as little 
as a single glycosidic bond or be completely void of all resemblance to one another except 
for attachment site on their conjugate – give rise to the term “glycoform.”1 Commonly 
used throughout the subsequent discussion and across literature of multiple disciplines, 
“glycoform” is used to denote variation between otherwise identical glycan-conjugate 
pairs. For sake of clarification, two glycoproteins identical in sequence, structure and 
modification except for a missing glycan on the latter are classified as unique glycoforms. 
Another example of differing glycoforms can be seen when two copies of the same 
glycoprotein are modified at the same site but the glycan on one protein incorporates 




residues. This trend continues to be true, so long as any structural or compositional 
difference exists between otherwise identical glycoconjugates. However, while further 
understanding the differences between – and characterization of – glycoforms certainly 
aids in explaining the complex phenomenon found within glycoconjugates, such an 
explanation would be considered superficial without first discussing the impacts of 
glycosylation and comprehending the biological importance found therein. 
1.2 Biological Significance of Glycosylation 
Numerous significant investigators from over a century of dedicated research 
have led to this point where such deep knowledge of glycoconjugates is readily available 
for retrieval and expansion. However, it would be disingenuous and irresponsible to 
ignore the reason behind the enormous dedication of time and energy allotted to 
glycobiology. The biological implications of glycoconjugates continually grow in 
number due to the sheer number of ways a glycan may function within an organism. And, 
though glycans could later be proved to participate in a litany of biological and 
biochemical pathways, currently, the importance of glycans is realized through their role 
in three classically recognized areas: structural and modularity roles – especially those 
pertaining to nutrient sequestration and storage, recognition and signaling pathways – 
commonly attributed to extrinsic and intrinsic glycan binding proteins, and molecular 
mimicry – the process by which foreign species emulate the modifications expressed by 
a host to inspire increased tolerance.1 Though a glycan may participate in one or all of 
these roles,1 the importance of all individual glycan moieties is still not fully realized. 




lifespan of the host organism, the effects of active glycans being quite subtle and difficult 
to recognize, and modulation in glycan activity based on the cellular or molecular 
environment.1  For these reasons and others, techniques commonly employed to elucidate 
glycan structure and function are often quite limited in success. (1.2.2) 
1.2.1 Glycans as Receptor Ligands and Viability Moderators   
 Though much time could be spent attempting to fully detail the ways in which 
glycans are utilized within different organisms, one of the most important and heavily 
studied areas of glycan interaction and function is the large class of protein messengers 
that recognize them – glycan binding proteins. Glycan binding proteins (GBPs) come in 
one of two varieties: intrinsic or extrinsic. Intrinsic GBPs are noted as such because they 
specifically recognize the glycans from an organism or conjugate identical to the one on 
which the GBP resides, where extrinsic GBPs are those that recognize glycans expressed 
by foreign organisms and substrates. As GBPs are a major – if not the predominant – 
class of glycan receptors, they serve as initiators of the many biological processes 
described above, (1.2) such as nutrient storage and sequestration. However, due to the 
importance of GBPs to the survival of the host organism, they are often used as a means 
of exploitation by invading species and pathogens. 
“Molecular mimicry” refers to the process by which microbial pathogens modify 
their exterior surface to incorporate the glycans exhibited by the host organism, usually 
to escape immune response or rejected recognition that would result in death of the 
invading species.1 This process is not to be confused with “molecular gimmickry,” where 




glycans – begins to slowly increase a host’s tolerance for the pathogen by acclimating it 
to lower levels of undesirable glycans. Both molecular mimicry and gimmickry serve to 
illustrate how integral glycan-protein interactions are to the overall viability of an 
individual organism. 
Furthermore, if the biological relevance of these protein interactions is accepted, 
it would imply that any gene defects revealed to alter protein function would also impact 
the modifications expressed on proteins or functions of the proteins that recognize them. 
Genetic defects of this type have been successfully promoted and observed in cell cultures 
through the alteration of growth conditions or introduction of stressors.1 When observing 
the result of genetic defects on an individual cell, there was very little effect, if any; 
however, when examining the same genetic defects within a complex organism, severe 
and catastrophic results were reported.1 These studies serve to, again, reinforce the 
significance of glycan expression and recognition, and also that the major roles of glycans 
operate mainly within intact, multicellular organisms.1 
Another pivotal, readily studied task of glycan modifications is protection from 
or redirection towards degradation. A simple example of protection can be found when 
examining bacteria. The glycocalyx, or paricellular matrix, that surrounds the cell 
membrane is largely composed of glycan chains extending away from their 
transmembrane glycoprotein conjugates. This matrix offers a level of protection from 
species that seek to attack or consume the bacterium by serving as a repository of glycans 
that can be beneficially recognized and also by acting as a physical barrier.1 However, 
where the glycans found in the glycocalyx act to prevent degradation, glycans deposited 




degradation. Glycosylation is noted as a competing factor to protein folding,1 meaning 
that glycans are transferred to the peptide backbone before or during the formation of 
secondary structures and that proper folding can only occur when the deposited 
modifications promote the preferred folded structure. Protein misfolding is a biochemical 
normality, and incorrectly folded proteins are typically marked for digestion and 
recycling, as has been noted time and time again. Therefore, since glycoproteins are 
successfully modified, secreted and allowed to function in all organisms, it must be 
reasonably concluded that proper protein folding takes place only when proper 
modification occurs. Conversely, improperly modified proteins may result in improper 
protein folding, preventing the conjugate from proceeding past the modification step in 
the endoplasmic reticulum (ER). The proteins residing in the ER long after release from 
the translocon will subsequently be redirected towards degradation.1  
In short, though glycans have been implicated in several pertinent biological 
interactions, of which those listed above are simply representative examples, the process 
of glycosylation is highly important to the full understanding of protein and organism 
function. Such a revelation would lead researchers to attempt to learn the exact function 
resulting from commonly occurring glycan chains, an endeavor pursued through 
countless techniques, each presenting limitation. 
1.2.2 Traditional Techniques for Glycan Analysis and Their Limitations 
Though there has been much knowledge obtained about the importance of glycans 
to the survival, growth, and responses within an organism, (1.2.1) there is a stark, 




exact functions confirmed to take place. Simply put, the sheer number of unique glycans, 
variable expression, and time-dependent importance of modifications make the endeavor 
of function assignment difficult, to say the least. But since nothing in biochemical 
research is ever straightforward, a brief explanation of common methods and their failures 
becomes necessary.  
One common technique researchers will use to determine how glycans are 
recognized within an organism is by introducing receptor probes. These receptor probes 
often come in the form of Galectin-Related Proteins (GRPs) – galectins being a conserved 
family of β-galactoside-binding proteins.4 GRPs will bind with the glycans expressed by 
the host organism, allowing all unbound species to be washed away, and the GRP-
glycoprotein complex can then be extracted and purified for glycan analysis. In theory, 
this approach would be beneficial for determining the specific modifications found within 
a certain class of organism but is limited by the fact that GRPs exhibit weak affinity, are 
multivalent, and their cognate ligands are usually present in multiple copies.1 These 
regretful properties of GRPs typically result in aggregation of receptor probes around 
certain cell types and could result in over-diagnosis of function.5 GRPs, therefore, require 
careful consideration and optimization before reaching reasonable success. 
Another common method for glycan analysis is to compare organism function 
under normal conditions and in the absence of any glycosylation by performing knockout 
experiments. A popular choice of workflow is to inhibit N-glycosylation through the 
introduction of tunicamycin,6 a mixture of antibiotics that inhibit N-Acetylglucosamine 




used in complex organisms because such knockouts often impact unrelated organism 
processes,1 making exact assignment of glycan function a near-impossible conclusion.  
One other, more specific, form of glycan recognition and detection is done through 
utilizing glycan binding proteins (GBPs). Because these proteins can recognize specific 
glycans, they are of great interest to researchers pursuing targeted analysis and seeking 
to detect the presence of certain glycan chains or glycoproteins. However, it has been 
noted that the monovalent affinity between a GBP and its ligand is often quite low, 
indicating a need for GBPs to be introduced in high density to facilitate detection.7 And 
as well, organisms are known to exhibit a variety of glycan structures in different tissue 
types at different times during development, meaning that GBP studies can result in 
interactions at a place or time that is of little biological relevance.1  
Though these are certainly not all the possible means of glycan and glycoprotein 
analysis, they are techniques that highlight both the efforts and limitations in analyzing 
present glycan moieties and further indicate that novel characterization studies are of 
immediate importance. However, before improved methods can be conceptualized and 
tested, it is necessary to understand the challenges presented when studying glycosylation 
so current analytical methods may be appreciated and potential limitations may be 
accounted for preemptively.  
1.3 Further Analytical Challenges in Glycosylation Studies 
When attempting to recognize and characterize glycosylation modifications 
through modern analytical techniques, hindrances abound due to the complexity of the 




enzymatically controlled process that results in multiple glycan products unique in 
structure and monosaccharide composition, which can be deposited on multiple 
modification sites in varying abundances. This reality makes appropriate discussion of all 
observable glycans an ambitious endeavor, necessitating a balance of consideration 
between the inherent diversity of glycans, and the glycans of immediate relevance. Seen 
below, (1.3.2, 1.4) glycans deposited on protein conjugates can be classified as either O- or 
N-linked, and both should be addressed to fully comprehend the complexity of 
glycoproteins; however, only N-linked glycans will be discussed in detail due to their 
broader diversity and relevance to the later work. (4.1) And to fully appreciate N-glycan 
diversity, it is important to first discuss the natural and incomparable phenomenon found 
in glycosylation that leads to extreme the difficulty of targeted analysis: 
microheterogeneity.  
1.3.1 Microheterogeneity  
“Microheterogeneity” is the colloquialism used to describe the existence of 
multiple compositionally and structurally unique glycans that can be found at a single 
modification site of a protein conjugate. One aspect of microheterogeneity that is 
commonly discussed is that of glycan structure – referring to the location of α and β 
glycosidic bonds. Two glycans, each composed of the same number and type of 
monosaccharides, could demonstrate completely different structures due to the previously 
discussed (1.1.1) ability of glycosidic bonds to exist between multiple stereocenters and in 
multiple orientations. When comparing glycosidic bonds to those of common polymeric 




polypeptide chains), it is obvious that glycosidic bonds are far and away greater in 
diversity, whereas phosphodiester and peptide bonds are highly conserved.  However, 
though structure is a significant consideration in the overall phenomenon of 
microheterogeneity, the more easily recognized component of the phenomenon comes 
when examining composition, rather than monosaccharide orientation.  
Comparing again to DNA and polypeptides, glycans share in the fact that there is 
a finite number of possible species that can be sequentially added during construction. 
DNA is composed of four unique nucleotides, polypeptides are composed of twenty 
common amino acids, and glycans are primarily composed of twelve commonly 
occurring monosaccharides, allowing one to extrapolate that glycans produce a diversity 
greater than DNA but less than polypeptides. This component of microheterogeneity is 
more readily noticed through analytical techniques because varying the number or type 
of monosaccharides incorporated into a glycan chain will exhibit changes in analyte 
character (e.g. greater mass, size, or hydrophilicity), whereas changes in glycosidic bonds 
typically do not.  
The microheterogeneity exhibited by glycoproteins is still quite a mystery, even 
to those who study it in detail, leaving many questions about the phenomenon 
unanswered. Analytical researchers are typically concerned with illuminating the variety 
and abundance with which different glycoforms are expressed in vivo – a question not 
easily answered even with the most proficient techniques. Furthermore, such a quandary 
is dwarfed by those attempting to understand the reason microheterogeneity takes place. 
In an attempt to provide explanation, two leading hypotheses exist to answer why 




modification by a series of competing enzymes that yield multiple unique glycans or ii) 
each cell type is responsible for – and specifically executes – the creation of a small 
number of glycosylated products and the microheterogeneity observed results from 
investigating multicellular sources. It could be that neither or both hypotheses are one day 
confirmed, but despite accepting or rejecting either, understanding the enzymes and 
processes by which glycoproteins are produced is necessary for full understanding of 
microheterogeneity and the following work. (4.1)  
1.3.2 Specificity and Activity of Glycosyltransferases (GSTs) 
 Glycosylation begins with the transfer of activated sugar residues (UDP-N-
Acetylglucosamine, GDP-Mannose, etc.) to the lipid substrate dolichol pyrophosphate 
(Dol-P-P) – the polar head of which is exposed to the cytosolic face of the endoplasmic 
reticulum (ER). The various enzymes that facilitate the transfer of sugar residues and 
formation of glycosidic linkages are referred to throughout as glycosyltransferases. 
Glycosyltransferases (GSTs) constitute a large family of proteins, the functions of which 
are often generalized as transferring an activated monosaccharide to an acceptor 
substrate. In general, it is thought that GSTs act linearly and sequentially so that the 
product of one transferase becomes the acceptor for another, but this is not to say that 
some GSTs cannot act simultaneously to give unique branched products. 
A notable characteristic of GSTs is that of their extreme specificity. It would be 
logical to assume that, as a glycan is constructed, a GST recognizes only the terminal 
monosaccharide and either will or will not carry out its function based on that ending 




that the activity of a transferase can preferentially select for a terminal sugar based on its 
connectivity to others, effectively indicating that GSTs recognize more than just a 
terminal residue. A practical example of this selectivity is seen in the human B blood 
group where α1-3 glycosyltransferase desires to transfer a galactose residue to the H 
antigen but will only do so if the substrate has been previously attached α1-2 to fucose.1 
Correspondingly, if one accepts the specificity of the GSTs constructing glycans, it is 
simple to imagine how the altered expression and activity of one GST would result in the 
production of extremely diverse glycan chains. Following the basic premise of 
sequentially acting enzymes, GSTs will elongate and mature glycan chains depending on 
cell type and modification class (i.e. different GSTs are used to produce O- and N-
glycans) until the time when they are ready to be transferred to a protein substrate, at 
which point a distinct group of transferases takes over.  
The GSTs most important for glycoprotein production and function are those that 
transfer the mono- and oligosaccharide moieties to the polypeptide backbone. Briefly and 
only superficially discussed herein, the transferases responsible for O-GalNAc (O-linked 
N-Acetylgalactosamine) modification do not recognize specific peptide motifs as 
modification “primers,” and instead deposit the mono- or oligosaccharide moieties on the 
hydroxyl group of any present Serine or Threonine residues, indicating these transferases 
may not demonstrate the same specificity discussed above. However, it should be further 
noted that though no peptide motif is required for O-glycan transferases, O-GalNAc 
modifications are typically found on less structured portions of folded proteins, 
suggesting a protein’s control over its modification or the preference of O-glycan 




hydroxyl-containing amino acid residues, it is possible for residues other than Serine or 
Threonine to be modified. These instances are rare, however, and may be considered 
exceptions to the central or relevant model of glycosylation. 
All N-glycans found in eukaryotic organisms are transferred to their peptide 
substrate by similar processes, which are initiated by one of two 
oligosaccharyltransferases (OSTs): Oligosaccharyltransferase A (OSTA) or 
Oligosaccharyltransferase B (OSTB). The function of these two transferase enzymes is 
essentially the same but are distinguished due to OSTA favoring nascent peptide 
substrates that are still associated with the translocon, whereas OSTB favors proteins that 
have separated from the translocon and have entered the ER. These two OST enzymes 
are significant compared to those facilitating O-glycosylation in that they specifically 
recognize the polypeptide motif Asn-X-Ser/Thr, where “X” may be any amino acid 
except for proline,1, 8-9 and transfer the oligosaccharide to the amine-group nitrogen of 
Asparagine. A possible explanation for the exclusion of proline in this motif is that 
proteins are noted to perform a 180° folding “turn” following a glycosylated residue, 
which would not be possible with the presence of proline.1 In either case, the ability of 
these transferase enzymes to recognize specific peptide sequences, again, points to the 
high level of specificity demonstrated by the transferases involved in the glycosylation 
process, reinforcing their impact on the overall phenomenon of microheterogeneity. Now 
topically understanding the underlying processes responsible for the construction and 






Where O-glycans form an α1 glycosidic bond between the hydroxyl group of 
either Serine or Threonine and are commonly comprised of an initial N-
Acetylgalactosamine (GalNAc), N-linked glycans form the initial β1 glycosidic linkage 
between the side chain nitrogen of Asparagine and a N-Acetylglucosamine (GlcNAc) 
residue.  As stated previously, (1.3.2) N-glycans are transferred only after recognition of 
the peptide motif (N-X-S/T), a trend that only disappears when examining cytoplasmic 
or nuclear proteins, which do not definitively express N-glycans.1 For the proteins that 
do express N-glycan modifications, there are three major classes into which the glycan 
moieties fall, all of which begin with the same core structure described below (figure 1.4): 
oligomannose – where mannose residues extend the core structure, complex – where 
GlcNAc residues form antennae that extend the core structure, and hybrid – where 
mannose extends the α1-6 arm of the core and GlcNAc extends the α1-3 arm (figure 1.4). 
1.4.1 Process of N-Linked Glycosylation  
Expanding on the earlier introduction to the process of glycosylation, (1.3.2) the 
glycan precursor, Dol-P, a polyisoprenyl moiety comprised of five-carbon units, receives 
the first activated sugar residue (GlcNAc-1-P) from UDP-GlcNAc with assistance from 
ALG7 – asparagine-linked glycosyltransferase 7. The oligosaccharide eventually reaches 
the classic core structure, GlcNAc2Man3, by sequentially adding to the primary 
monosaccharide one GlcNAc residue and three Mannose (Man) residues in branched 
fashion (figure 1.4). Upon the transfer of two additional Mannose residues, the glycan 




exposure to the luminal region (figure 1.5). The maturing GlcNAc2Man5 glycan must be 
actively transported across the hydrophobic bilayer due to the extreme hydrophilic 
character now present from the extending sugar chain – a process similar to that of the 
classic ABC transporter, facilitated by the flippase2 RFT1.1 It should also be noted that 
the continued growth on the luminal side of the ER membrane is still dependent on the 
presence of activated sugar residues (GDP-Man and UDP-Glc) that must also be actively 
transported across the ER bilayer via flippase proteins. Once exposed to the luminal 
region of the ER, the glycan continues to grow in length by four mannose residues and 
three terminal glucose residues – the first two exhibiting α1-3 linkages and the third being 
bound α1-2, which act as a signal of finality. Upon recognition of these terminal glucose 
residues, the entire oligosaccharide (GlcNAc2Man9Glc3) is transferred to the available 
peptide backbone by OSTA or OSTB (figure 1.5). 
1.4.2 Heterogeneity Found in N-Glycans 
Though the complete process of glycan construction and transfer can be 
characterized as above, leaving the discussion as is would be to ignore the later steps that 
contribute to microheterogeneity. Briefly, after the mature GlcNAc2Man9Glc3 glycan 
becomes attached to the protein backbone, the terminal glucose residue is removed by α-
glucosidase I, with the inner two following via α-glucosidase II. Before the newly 
modified glycoprotein exits the ER, ER α-mannosidase I removes a terminal mannose 
residue from the central arm to form the GlcNAc2Man8 glycan – a process that continues 
in the cis-golgi to produce GlcNAc2Man5 glycans. If the GlcNAc2Man5 proceeds without 




9 modifications. If the GlcNAc2Man5 continues in processing, the glycan will grow to 
form complex or hybrid moieties.1  
Further contributing to microheterogeneity, it is obvious not every protein in an 
organism’s proteome will contain the peptide motif necessary for N-glycosylation, and 
not every motif present will receive a modification. It is predicted that approximately 
70% of proteins contain the motif and 70% of all motifs are modified1 – bolstering the 
glycoform/microheterogeneity conundrum. When it comes to the peptide motif itself, 
there is very little information that exists to expand upon its selective nature, but some 
have noted uncommon exceptions where Cysteine occupies the third position rather than 
Serine or Threonine. The second position, in the same respect does not seem to affect 
glycosylation overall but may help reduce binding when occupied by an acidic residue 
(i.e. Aspartate or Glutamate) and may help promote binding when occupied by 
Phenylalanine. Such changes in motif are also contributors to the overall diversity found 
when examining N-glycosylation. 
1.5 Conclusion 
Resulting from the highly diverse nature of glycan structure, the large number of 
monosaccharides that may be incorporated, and the specificity and varying activity of 
enzymes participating in the complex modification process, glycosylation presents 
unparalleled complexity, compared to other PTMs. In accordance with this extreme 
diversity, glycans are implicated in many relevant molecular pathways and are of 
immediate biological and clinical concern. However, the study of glycans through 




before meaningful analysis may be performed. For this reason, proteomic analysis of 
glycoproteins typically employs a broad range of sophisticated techniques that do not rely 
on biochemical processes, making proteomics-based studies more beneficial for detection 
and analysis of glycoforms, but limited in their revelation of biological underpinnings. 
However, though many analytical methods are available for use, and more are validated 
as time goes on, it continues to be seen – and is described below – that analytical 
approaches lack the ability to cope with the overwhelming intricacies of glycosylation, 









Figure 1.1 Aldo- and Keto- Sugars  
All commonly occurring sugars exist as isomers or expansions of fundamental aldo- (left) 
or keto- (right) sugar molecules, such as these representative molecules. The anomeric 
carbon, highlighted in red, represents the reducing end and corresponds to the chiral 
center responsible for forming glycosidic bonds. Glycosidic bonds are formed between 












Figure 1.2 Glycosidic Bond Formation 
Glycosidic bonds are delineated based on multiple characteristics. The first point of 
distinction is based on the respective stereochemistry of the anomeric carbon and carbon 
center furthest in distance – alpha (α) corresponding to identical orientation (a) and beta 
(β) corresponding to opposite orientation (b). Furthermore, glycosidic bonds can be 
formed between the reducing end of one monosaccharide and any hydroxyl-containing 
carbon on another and are labeled according to the carbon centers that terminate the 
glycosidic bond.1 Carbons of monosaccharides are ordered such that the anomeric carbon 








Figure 1.3 Classes of Commonly Occurring Monosaccharides 
The six classes of monosaccharides, within which all commonly occurring sugar residues 
are grouped – pentose (a), hexose (b), hexosamine (c), 6-deoxyhexose (d) uronic acid (e) 









Figure 1.4 N-Glycan Core Structure and Recognized Classes 
(a) The core structure of all N-glycans, composed of two primary N-Acetylglucosamine 
residues and three Mannose residues. Original figure. (b) Three recognized classes into 
which all N-glycan moieties are placed. N-glycans are categorized as either 
oligomannose – or high mannose (left), complex (center), or hybrid (right).1 Reprinted 
with permission from Varki, A. (2009). Essentials of glycobiology. Cold Spring Harbor, 










Figure 1.5 N-Glycosylation Pathway 
Graphical depiction of the formation, elongation, and transfer of oligomannose N-
glycans. The precursor, dolichol-phosphate (lower left) receives the initial and 
subsequent monosaccharides from various asparagine-linked glycosyltransferases (ALG) 
until reaching a terminal length of GlcNAc2Man9Glc3, at which point the oligosaccharide 
is transferred to the nascent or maturing protein by OSTA or OSTB, respectively.1 
Reprinted with permission from Varki, A. (2009). Essentials of glycobiology. Cold Spring 





Chapter 2: Proteomics-Based Glycosylation Studies 
2.1 Considerations for Glycoform Analysis 
When arriving at the decision to study glycoproteins, whether through an 
established method or novel approach, several considerations must take place to ensure 
reasonable success. At the heart of most analytical glycoprotein studies – assuming one 
is studying a single or small set of glycoconjugates, the general interest lies in either 
obtaining information pertaining to the structure and composition of glycans or in 
determining the number of distinct glycoforms present, when only the more ambitious of 
studies aspire to do both. Attempting to assign structure to glycan modifications is 
arguably the more difficult of the two, because structural revelations of glycans relies on 
successful cross-ring fragmentation through mass spectrometry (MS) or in highly-
specific liquid chromatography (LC) techniques.10-12 Such methods have been proven 
successful with regular improvements in analytical techniques, but are hampered by the 
fact that diverse glycans require diverse identification methods, making the successful 
technique used for some sample types and their glycans unsuccessful for others. This fact 
would lead one to believe that the most useful techniques for glycan analysis are those 
that can be universally applied – a point reinforced in the later work. (4.1) 
2.1.1 Top-Down Proteomics and Limitations in Glycoprotein Analysis 
On the other hand, if one is seeking to profile all the different glycoforms that 
may be present in a given sample or set of conjugates, the prevailing strategy is to take 




(figure 2.1) refers to the investigation of intact proteins and is usually done through mass-
spectrometry (MS) analysis of purified proteins or analysis of protein mixtures separated 
by liquid chromatography (LC) prior to mass spectrometry. When applied to glycoprotein 
studies – or the study of virtually any protein – mass spectrometry analysis reveals the 
accurate mass measurements of all intact proteoforms present in the sample.13 Top-down 
proteomics is an area of relative infancy compared to the bottom-up approach discussed 
later, (2.2) and is not without its limitations.  
Top-down is usually most successful when applied to a well-purified, single 
protein or a complex mixture of proteins that is comparably well-separated. This is 
because, as noted before, (1.3.1) the microheterogeneity present in glycoproteins would 
make a complex mixture of diversely modified proteins quite difficult to characterize 
without careful optimization due to the possibly overlapping signals present on the 
spectra.13 Another challenge to using the top-down approach is the fact that various 
glycoforms will inherently be more abundant than others, and will, therefore, suppress 
the MS signal for the low-abundant glycoproteins that are present,14 making detection of 
some potentially important glycoforms an endeavor of its own. And even if this top-down 
approach is taken, the beauty and accuracy of MS measurements can also be considered 
a drawback. Since glycans are so diverse in their composition – incorporating many 
different sugar residues that may have the same molecular weight15 (table 2.1) – achieving 
an accurate mass measurement of a given glycoprotein would not actually provide any 
reasonable distinction of glycoforms modifications without further analysis. Furthermore, 
as top-down methods are still quite limited in their ability to facilitate peptide sequence 




outside the realm of immediate possibility. These limitations may indicate one would be 
better served by focusing all attention on the glycan chains themselves, which may be 
released from the protein and studied more efficiently. 
2.1.2 Drawbacks of Enzymatic Glycan Release 
 Top-down analysis of glycoproteins, regardless of the above limitations that must 
be overcome, does provide great insight into the diversity and number of glycoforms 
presented in a given sample, but lacks significant capability to do meaningful 
characterization. Therefore, one may conclude it would be easier to release all the glycans 
present on protein and study them individually. Glycan release is typically accomplished 
by introducing PNGase F16-19 – an amidase capable of hydrolyzing the glycosylamine 
linkage of a broad range of substrates – or pronase20-22 to a purified or a mixture of 
glycoproteins, allowing their intact glycan chains to be further analyzed. However, 
though these methods can be useful in determining all the different types of modifications 
present on a given protein, once a glycan is released, all ability to assign it to a specific 
modification site on the protein has been lost. The release of glycans from their conjugate 
protein is, therefore, detrimental to the endeavor of discovering modification function 
because knowledge of glycan structures is valuable but, to an extent, meaningless if the 
correlation to active or binding sites of the protein are impossible to determine.  
Upon realizing both that site specificity is necessary to holistic protein 
characterization and that top-down protein analysis could be quite limited for various 




methods that incorporate the benefits found in both. To this end, studying glycoproteins 
in a bottom-up fashion seems ever more reasonable and preferential.  
2.2 Bottom-Up Glycoprotein Analysis 
Due to its breadth of application and decades of revision and improvement, 
bottom-up remains the most popular method for proteome analysis. The “bottom-up” 
approach is so named for its focus on taking native proteins, denaturing them, introducing 
a protease, and then studying the resulting peptides.23-25 Bottom-up techniques have been 
extensively utilized for a broad range of applications, because they can be greatly 
optimized to allow for high-throughput characterization and quantification of proteome 
content.25 As bottom-up studies are generally applied to a workflow utilizing MS, the 
preceding separation and enrichment methods utilized are an area of great importance and 
interest to researchers.  
Focusing on the analytes of immediate concern to the following work, (4.1) it is 
fortunate that, when all things are taken into consideration, glycopeptides usually exhibit 
enough unique characteristics to find a suitable chromatography method to differentiate 
them both from unmodified peptides and from one another – though no universal 
approach is accepted for all glycoprotein/glycopeptide studies. Some traditional methods 
of glycopeptide separation include lectin chromatography,26-27 boronate 
chromatography,28-31 hydrophilic interaction chromatography (HILIC),32-36 and porous 
graphitized carbon chromatography (PGC)37-38 all of which offer complementary 
information to one another based on peptide character, and can be coupled together to 




can be applied to more than one sample type, but each reaches limitations when the 
complexity of sample increases. Also, an unfortunate reality of glycoproteins is that the 
number of glycopeptides resulting from proteolytic activity will be low in abundance 
compared to the unmodified or non-glycosylated peptides from the same protein.19 
Accordingly, to do meaningful analysis or quantification for a set of glycopeptides, 
sample enrichment is often necessary prior to LC separation – a step that may involve 
careful optimization and may only be beneficial for a small set of glycoproteins.  
Enrichment set aside, regardless of how successful or popular a chromatography 
technique may be, the question of microheterogeneity still exists. If glycopeptides are to 
be separated according to hydrophilic character, for example, this implies that two 
identical glycopeptides that differ only in position of glycosidic linkages found within the 
glycan will not differ in terms of hydrophilicity while being recognized as unique 
glycoforms. The presence of these isomeric species in bottom-up glycopeptide studies 
has gained tremendous attention and should effectively be considered its own area of 
study. To date, there exists very few chromatographic separation techniques that facilitate 
the separation of glycopeptide isomers, with relative success being found in analyzing 
permethylated glycopeptides through PGC at high temperatures.39-41 However, the 
separation and characterization of isomeric species is neither the goal nor the focus of the 
following work. In order for any isomeric studies to take place, accurate separation of 
glycoforms would be necessary, which is not readily achieved through commonly applied 
methods. This lack of adequate glycoform distinction is, therefore, the area requiring 




The challenges to glycoform analysis are far more abundant than simply 
relegating it to a matter of isomeric separation. Knowing that a single protein may contain 
multiple glycosylation modification sites, and that each site may exhibit several unique 
glycan chains of different composition, one can imagine the complexity that would be 
seen when comparing all the present, unique glycopeptides resulting from one protein 
conjugate. Using the same logic, one may extrapolate that multiple protein copies or 
mixtures of several glycoproteins would exhibit an almost insurmountable level of 
diversity in glycopeptide composition. This being true, it would be insufficient to rely on 
a single separation component to accurately distinguish each glycoform because there 
would almost certainly be overlap in analyte character (hydrophobicity, hydrophilicity, 
lectin affinity, etc.), regardless of the separation dimension utilized. And even if a single 
separation technique was suitable for this endeavor, such methods would be dependent 
on accurate enrichment, derivation, and separation prior to MS analysis, decreasing their 
overall flexibility and universality. Recognizing the stated importance of glycoform 
separation and characterization8, 10, 42-43 and the limitations of accomplishing this through 
LC, it is noted that an additional separation component would be useful in glycoform 
analysis and that gas phase separations could provide information complementary to that 
readily achieved through traditional techniques.19  
2.3 Conclusion and Future Directions 
Glycoprotein analysis is a complicated endeavor. Utilizing mass spectrometry is 
undoubtedly the most preferential analytical technique and may, therefore, be assumed 




in glycoproteins, there are many ways MS may be applied to glycoform analysis, each of 
which offers limitations. Top-down analysis of glycoproteins will provide revelation of 
the glycoforms present but cannot distinguish between glycoforms of identical mass, 
would struggle to identify any glycoforms that are in low abundance, and is limited in its 
capacity to offer site-specific information. The enzymatic release of glycans from a 
conjugate would allow for analysis through LC-MS and therefore provide detailed 
structural information but eliminates any site-specificity and, therefore, the possibility 
correlating modifications to active protein sites. Bottom-up analysis offers advantages 
compared to top-down and glycan release through the retention of site-specific 
information and the ability to provide structural and compositional details. But for bottom 
up studies to be successful, glycopeptide enrichment and separation is necessary and the 
chromatography techniques commonly employed lack the power to distinguish analytes 
of subtle difference and cannot be applied to all glycoprotein or glycopeptide samples. 
These realizations indicate the need for further method development. Firstly, one 
must pursue a method that utilizes bottom-up analysis in order to retain site-specific 
information. Further, the method should include a means of glycopeptide separation and 
enrichment from a complex mixture that can be universally applied to all sample types 
and operate independently of glycopeptide complexity. And finally, there must be a 
means to distinguish glycoforms from one another, regardless of any subtle differences 
in composition. Such a method is certainly feasible, as demonstrated below, (4.1) but 
should not be confined to separations in the liquid phase. Due to the endearing breadth of 
gas-phase separations and the information they provide, such methods must be considered 





Figure 2.1 Top-down and Bottom-up Proteomics 
Pictorial representation of top-down and bottom-up proteomics workflows. Top-down 
analysis relies on protein extraction and purification, at which point native proteins will 
be analyzed by mass spectrometry, revealing accurate mass measurements useful for 
revealing the number of glycoforms present. Bottom-up techniques rely on proteolytic 
cleavage of proteins and examination of peptide masses to determine the presence of 








Monosaccharide  Class Accurate Mass (Da) 
Glucose Hexose 180.1559 
Galactose Hexose 180.1559 
Mannose Hexose 180.1559 
Fucose Pentose 164.1565 
Glucosamine Hexosamine 179.1711 
Galactosamine Hexosamine 179.1711 
N-Acetylglucosamine Hexosamine 221.208 
N-Acetylgalactosamine Hexosamine 221.208 
Glucuronic Acid Uronic Acid 194.1394 
Ascorbic Acid Uronic Acid 176.124 
Sialic Acid Nonulosonic Acid 309.27 
N-Acetylmuramic Acid Nonulosonic Acid 293.2705 
 
Table 2.1 Commonly Occurring Monosaccharides 
Though a staggering number of unique monosaccharides have been identified in vivo,1 a 
small set are considered commonly occurring. One notable feature of these common 
monosaccharides is that, often, residues within the same class exist as isomers of one 
another, exhibiting only structural differences, and, therefore, have identical molecular 
weights. This adds to the difficulty of glycan analysis in that obtaining accurate mass of 





Chapter 3: Gas Phase Separations Prior to Mass Spectrometry 
Gas phase separations as a means to further analyze chemical products stemmed 
from the initial discoveries pertaining to the formation and behavior of ions in ambient 
gases,45 which are considered to be strongly linked to the studies of lightning that began 
in the 1700s46 and the continued interests in electricity in the following century.45, 47  Now 
collectively referred to as Ion Mobility Spectrometry (IMS), such studies have undergone 
decades of increased interest, conception, and modified design in governmental, 
industrial, and academic settings being valued as technique useful for its speed, durability, 
and reliability.45 Though only the most in-depth writings would provide a complete 
understanding of IMS, a brief explanation of IMS features and relevant applications 
should be provided to better comprehend the following work described in Chapter 4.  
3.1 Introduction and Mathematical Derivation of Mobility, K 
As the name suggests, ion mobility spectrometry techniques are built around the 
utilization and exploitation of the mathematically defined mobility (K) that is both 
inherent and unique for a given ion in the gaseous phase when introduced to an electric 
field. To obtain a superficial and working knowledge of such IMS techniques, it would 
be simple to say that every observable ion exhibits unique movement in response to an 
electric field and can, therefore, be separated from others due to that quantifiable 
difference. However, since ion mobility techniques continue to grow both in number and 
complexity, such a simple explanation of this ion characteristic would be insufficient. For 
this reason, we must briefly look at an expansion of traditionally accepted physics48 to 




Molecular diffusion is defined by Fick’s First law: 
 𝐽𝑚 = −𝐷∇𝑁 (2.1) 
where 
JM is the molecular flux (number of molecules flowing through unit area 
per unit time) 
∇N is the concentration gradient 
D is the diffusion coefficient, a molecular characteristic 
 














kB is the Boltzmann constant 
T is the gas temperature  
µ is the reduced mass of the diffusing and gas molecules – m and M, 
respectively 
N is the number density of gas molecules  
 
 
 𝜇 = 𝑚𝑀/(𝑚 + 𝑀) (2.3) 
Ω, the value introduced above (equation 2.2), refers to the orientationally averaged 
collision integral of a species. Since the orientation of the diffusing and gas molecules are 
random, there exists an infinite number of orientations present. However, to give a more 
definite value, Ω is equivalent to only the first collisional integral defined in the transport 
theory49 and Ω is, from here on, equated to the collisional cross section (CCS). Once the 
diffusion of molecules in gas and its relation to CCS are realized, one may dive deeper 




Defined by Newton’s second law, Ions of charge q that are subjected to a fixed 
electric field, E, experience a force constant and equal to qE. Further described by the 
same law, in the presence of a vacuum, ions fly with constant acceleration, 𝜃.  
 𝜃 = 𝑧𝑒𝐸/𝑚 (2.4) 
where 
z = q/e is the ion charge state 
e is the elementary charge 
 
Ion velocity, v, accordingly, increases linearly with time, t: 
 𝑣 = 𝑧𝑒𝐸𝑡/𝑚 (2.5) 
In the presence of an electric field, however, ion velocity cannot simply increase without 
end. Objects subjected to Coulomb force – or any force, for that matter – will eventually 
reach terminal velocity, referred to as drift velocity, v. In IMS, each species has a unique 
v and is separated by mobility, K. 
 𝐾 = 𝑣/𝐸 (2.6) 
This mobility value can be linked to the gas-phase diffusion value through the Einstein 
relationship (or the Nernst-Townsend-Einstein relationship): 
 𝐾 = 𝐷𝑞/𝐾𝐵𝑇 (2.7) 
















     Such mathematical derivations serve only to demonstrate the nature of mobility, K, 
that is discussed in the following sections. The differences of this property between all 
observable analytes is what gives IMS its unique separation capabilities. 
3.2 General Features and Design of Drift Tube Ion Mobility 
 As the name suggests, Ion Mobility Spectrometry (IMS) is based on the 
quantifiable difference in mobility between ions of unique characteristics. The overall 
design of such IMS instruments is discussed below, and while instrument design 
modulates as needed, the overall concept remains the same. Traditional measurement 
methods of IMS come through the determination of drift velocities for gaseous ions in 
the presence of a weak electric field.45 Knowing this truth, much consideration has been 
given to the formation and behavior of gaseous ions from neutral samples. However, 
though ion behavior is dependent on origin and environmental conditions, the overall 
consideration of ion formation is of little consequence to understanding the following 
work.  
Ions for IMS measurement were originally produced using chemical ionization50  
but are now created through common, modern ionization techniques such as electrospray 
ionization51-53 (ESI) and matrix-assisted laser desorption ionization54-56 (MALDI). 
Regardless of ionization technique, all ion mobility instruments function around transfer 
and introduction of these ions to the separating region of the instrument referred to as the 
“drift region”45 (Figure 3.1). However, though it is possible – and certainly simpler – to 
allow the continuous flow of ions between the ionization source and the drift region, such 




before, IMS analysis relies on the measurable difference of ion velocities through the drift 
region, and if there is no definite start time for a given group of ions, there is no way to 
determine how long an ion spends within the drift region, making velocity calculations 
impossible. For this reason, and to ensure adequate signal intensity, entrance to the drift 
region is regulated by an ion shutter.45, 57 The ion shutter (or ion gate) is an electric field 
only strong enough to cause ions to yield without repulsion. Prior to analysis, the ion 
shutter is “closed,” allowing ions to accumulate at the interface between the ionization 
and drift regions, then “opened” for a brief period (50-200 µs, depending on method 
conditions) dispensing ion swarms into the separating region.45 While being pushed 
toward the detector with a constant electric field, there is simultaneous competition to 
forward mobility due to the presence of the drift gas. This drift gas, usually an inert 
species such as Nitrogen or Helium, collides with the ions in the drift region – more ion-
gas interactions occurring for ions with larger cross-sectional diameter. These ion-gas 
collisions result in the decreased drift velocity of all analytes, forcing them to arrive at 
the detector in a manner proportional to their collisional cross section. The output values 
from IMS instruments are measurements of arrival time – how long it took an analyte 
with a given mass-to-charge ratio (m/z) to reach the detector – and may be used to 
determine CCS. The quantification of CCS values has many uses cases and is a technique 
that has increased in popularity as demand changes, especially when attempting 
differentiate species on subtle differences in composition or structure. However, careful 
deliberation of design features is necessary when relying on gas-phase interactions and 




3.3 Consideration of Gas Composition and Pressure 
Since Ion mobility studies are also built around establishing an electric field 
across a region of gas, it is important to consider the nature of the gas that is present. 
Logically, if mobility is related to the strength of the applied electric field (equation 2.6), 
instrumental design will benefit from applying electric fields of varying magnitudes. 
However, the maximum limit of electric field strength is determined by the point at which 
the electric field overcomes the buffering capability of the gas between the electrodes – 
a process referred to as electrical breakdown. In the presence of a pure gas, the voltage 
needed to break through a gas field between electrodes of distance d depends on the 
pressure of gas present, Pd, as demonstrated by Paschen Curves
48, 58 (figure 3.2). 
Therefore, as defined for an individual gas, there is a minimum pressure that must exist 
to avoid breakdown at a given voltage. And as different gases exhibit unique Paschen 
curves, gas selection becomes a balancing act of finding the gas that will allow for the 
maximum electric field, while still providing significant separating collisions with the 
diffusing molecules.  
3.3.1 Ideal Drift Gases and Electron Scavengers 
Gases that are defined as “electron scavengers” – or those with high electron 
affinity – may serve to decrease the pressure necessary to avoid electrical breakdown 
compared to poor insulators found in small, light, low electron affinity species such as 
H2, He, and other noble gases.
48, 58 For example, sulfur hexafluoride, SF6, is a common 
insulator for exposed conductors at high voltages58 and would therefore be an ideal 




and other halogenated compounds that are harder to breakdown – are excellent electron 
scavengers due to their high electron affinity, and their relatively large mass and size 
provide a lower mobility, K, than the diffusing molecules. This lower mobility will 
decrease the energy of collision with the diffusing molecules, reducing the likelihood of 
drift gas ionization.48 And, as proven advantageous in industrial applications, the addition 
of a scavenging gas would raise the breakdown threshold disproportionately to the 
fraction of scavenger added when using pure scavenging gas is not desirable.48  
However, if we are to consider gas molecules as a separating component in some 
IMS systems, and we now know that IMS is dependent on collisional cross section, the 
size of gas molecules must be given equal consideration as that of their buffering capacity. 
Knowing that CCS is an average of all the infinite possible rotational collisions between 
a diffusing ion and gas molecule, one can crudely approximate the relationship between 
Ω, average ion radius, 𝑟𝐼, and average gas radius, 𝑟𝑔, as Ω = 𝜋(𝑟𝐼 + 𝑟𝑔)
2. Given this 
approximation, it is easy to see that the dependence of Ω on 𝑟𝑔 weakens as 𝑟𝐼 increases, 
making the effect of gas radius more pronounced for ions with smaller dimensions48 
(figure 3.3). This same principle can be applied to isomeric species of different spatial 
geometry. For example, non-spherical (oblate or prolate) species would be greatly 
affected by gas molecule dimensions compared to its near-spherical isomer due to the 
sheer difference in surface area.48 In summary, though gases with large mass, size, and 
electron affinity may provide the greatest buffering capacity to avoid electric breakdown, 
the sole use of such a gas in IMS is both impractical and mathematically disadvantageous. 




IMS applications and electrical breakdown is avoided by sacrificing electric field 
intensity or increasing gas pressure. 
3.4 Proven Applications of Ion Mobility Spectrometry 
 Ion mobility spectrometry is a unique and powerful method of analysis that is of 
great interest to researchers, stemming from its orthogonality to other readily-
implemented separation and analytical techniques. “Orthogonality” refers to the 
measurement of one technique offering information complementary to –  and independent 
of – another method and is a fitting description when comparing IMS to other common 
separation techniques. Traditional separation and analysis methods, such as those detailed 
earlier, (2.1-2.3) rely on LC-MS techniques that sort analytes according to attributes 
displayed in the aqueous phase, after which their accurate mass can be determined. IMS, 
on the other hand, can take the analytes sorted over time by LC and then distinguish them 
further according to CCS before detecting their mass, making the information obtained 
from the two separation methods orthogonal to one another. For this reason, as well as 
the obvious ability to analyze compounds that exist in the gas phase, IMS has been 
extensively applied across academic, government, and industry settings. However, 
though IMS can be used in a high-throughput manner – detecting everything abundant 
enough to be observed – commercial, governmental, and industrial ion mobility 
instruments are more often tuned to detect a given list of analytes.45 Examples of these 
endeavors include instruments optimized for detecting explosives and volatile 
compounds,60-62 drugs of abuse,63-65 and impurities found in air,45 food,66-67 or other 




individual use cases, a key benefit to using IMS for analyte detection is the ability to 
differentiate between isomeric species3, 68-69 or those exhibiting subtle structural and 
compositional differences not distinguished through LC. 
3.4.1 Relevance of IMS to Current Work  
 Since ions present in the drift region of IMS are actively proceeding against a field 
of drift gas, it is easy to imagine that ions of nearly identical mass, but noticeably different 
CCS will be affected accordingly. This difference in response can accurately separate any 
analyte species, even on the isomeric level, which is a classic example of IMS usefulness 
and is briefly explained here. However, it should be noted, as stated previously, (2.2) 
isomeric separation is not the end goal of the resulting research and must therefore only 
be discussed to better appreciate the substantial separation capacity of ion mobility 
techniques. 
Though constitutional isomers would certainly be separated in the drift region of 
IMS, such species would more than likely exhibit different attributes in the aqueous phase 
and could be sorted by LC alone. Conformational, geometric, and diastereomers, on the 
other hand, would be more prone to behave identically in LC and would, therefore, need 
further analysis to enable characterization. Since each of these isomer classes would have 
unique average collisional cross sections, they would interact with IMS drift gases 
accordingly and would reach the detector at different times. And though isomeric 
separation is not of immediate concern to the following work, the ability of IMS to 
discriminate analytes on very small changes in composition would make it extremely 




complexity of bottom-up glycoforms. Such methodologies have been validated and the 
discoveries resulting from numerous applications of IMS to glycopeptide and glycan 
studies are expansive17, 70-74 – some of which will be discussed briefly. And though it may 
be unfair to only superficially discuss these endeavors, the omission of an accurate 
retelling should serve only to reinforce the fact that countless endeavors have been 
successful. However, IMS is not the only separation technique that has been applied to 
chemical analysis, so focusing on traditional ion mobility spectrometry would prevent a 
well-formulated decision prior to experimental design.  
3.5 Expanded Ion Mobility Instrumentation 
 Elaborating upon the now relatively understood concept of traditional, drift-tube 
IMS, there are other forms of ion mobility studies that have been developed over the last 
several decades that may be introduced. Techniques exploiting the inherent mobilities of 
gas phase ions are continually growing in number and rampant in application. Some of 
the more popular and widely used methods are traveling wave ion mobility spectrometry 
(TWIMS), trapped ion mobility spectrometry (TIMS), and differential mobility analyzers 
(DMA). Briefly, TWIMS and TIMS function similarly to traditional IMS in that these 
methods are all based on the inherent mobility for an analyte,75 with the main differences 
coming in how mobility is exploited in these various applications. Where IMS uses an 
electric field to continuously push ions forward while a drift gas counteracts the motion, 
TIMS works similarly but pushes ions toward the detector using gas and employs electric 
fields to “trap” ions in the region where the force applied by the gas is equivalent to the 




ions through the present electric field but does not use gas as a propulsion component. 
Rather, as the name would suggest, a sequence of uniform, symmetric potential waves is 
continually sent through the drift region, propelling ions forward according to their 
mobility.75 Therefore, since ions of different character naturally exhibit unique mobility, 
ions will exist in the separation segment of the instrument for unequal times75 (figure 3.5).  
DMA, the method most unlike the others stated above resembles that of a more 
“targeted” approach. In differential mobility analyzers, ions are introduced between 
electrodes set at a specified distance and a sheath gas that pushes ions at an angle 90° 
from the angle of entrance. Simultaneously, there is an established electrical field 
between the electrodes that acts upon the ions in the same vector they originally moved 
at introduction. At the end of the electrodes is a small opening that leads to the detector, 
allowing for the detection of only the ions that exhibit the proper response to both the 
sheath flow and the electric field77 (figure 3.6). While this approach enables more specific 
detection, it is hindered by the fact that the applied electric field only operates at one 
voltage at a time – meaning the separation component of the device must be “scanned” 
or set to change over time. However, differential ion mobility does leave several factors 
to be considered. The separating component can be changed and, therefore, can be held 
constant to further analyze a species, the design of differential mobility instruments is 
often greatly simplified compared to that of IMS,45, 78 and such devices can sort analytes 
according to a character different than their CCS-defined mobility.75, 78 For these reasons, 
as well as to facilitate comprehension of the following work, discussion of another ion 




3.6 High-Field Asymmetric-Waveform Ion Mobility Spectrometry (FAIMS) 
High-Field Asymmetric-Waveform Ion Mobility Spectrometry, or FAIMS, 
contrasts quite severely to the ion mobility techniques discussed previously both in its 
recognition as the only true differential ion mobility separation method48 and in its general 
design considerations. In FAIMS, ions do not travel against the flow of gas as in the drift 
region of some IMS instruments, but rather they are pushed toward the detector by a 
carrier gas78 that is optimized for separation, resolution and detection48 – a component 
that will be further discussed. Bearing some superficial similarities to DMA, Ions are 
introduced to FAIMS at an angle 90° to the flowing carrier gas in between two planar or 
circular electrodes.48 However, instead of a constant electric field being applied with 
uniform direction – such as the field present in DMA devices – FAIMS utilizes an 
asymmetric radio frequency (RF) voltage to apply two fields of unique magnitude. 
3.6.1 Effects of Asymmetric Electrical Field on Ion Behavior  
 Asymmetric voltage application, an imperative component to FAIMS, incurs 
oscillation between a high and low electric field such that the high field operates for one 
time unit (t), and the low field – at negative one-half the voltage of the high field – 
operates for two time units48, 78-79 (figure 3.7). In Layman’s terms, the asymmetric 
waveform must be characterized by having equal area under the curve for the high and 
low fields and can be further represented by the formula 





E1 and E2 are the high and low fields, respectively  
t1 and t2 are the amounts of time for which each field is applied 
 
This combination of high and low fields in the presence of a carrier gas makes it so field-
dependent analytes between the electrodes exhibit two unique mobilities – one in the high 
field and one in the low, whereas other ion mobility techniques exploit a constant mobility 
coefficient. Thusly, ions will exhibit a greater – or at the very least, unequal – response 
to either the high or low field causing ions to alternatively migrate towards one electrode 
or the other, depending on which field imparts the greatest effect, eventually resulting in 
collisions and loss of ions.48, 78  
 The unequal migration can also be mathematically defined for further explanation. 
If the mobility of an analyte were to be independent of field intensity, the following 
equation would be satisfied: 
 𝐾(𝐸1) = 𝐾(𝐸2) (2.10) 
Exclusively in this case, ion motion between the electrodes as high and low fields are 
applied would be both equal in magnitude and opposite in direction. 
 𝐾(𝐸1)𝐸1𝑡1 = −𝐾(𝐸2)𝐸2𝑡2 (2.11) 
However, for ions with dependence on mobility, the difference in migration distance 
toward one electrode would be a non-zero value  
 𝐾(𝐸1)𝐸1𝑡1 + 𝐾(𝐸2)𝐸2𝑡2 ≠ 0 (2.12) 
and would therefore be displaced along the y-axis, the direction of which would be 




 𝐾(𝐸1)𝐸1𝑡1 + 𝐾(𝐸2)𝐸2𝑡2 = ∆𝐾𝐸1𝑡1 (2.13) 
for ions with a positive dependence on mobility  
 𝐾(𝐸1)𝐸1𝑡1 + 𝐾(𝐸2)𝐸2𝑡2 = ∆𝐾𝐸2𝑡2 (2.14) 
for ions with a negative dependence on mobility  
The extent of such displacement between the electrodes is mathematically and practically 
determined by field amplitude (Ex), waveform ratio (t1/t2) and ion mobility dependence 
(ΔK).78 
Now understanding the natural tendency for analytes to have displaced motion 
between the electrodes, another voltage must be applied to “correct” ions toward the 
center of the electrode gap. This superimposed DC voltage – referred to throughout as the 
compensation voltage, Cv – enables only certain ions to advance to the detector (figure 
3.8), similar to the process found in DMA. Since the compensation voltage that will 
prevent electrode collision is unique for each species – and because such a voltage is 
dependent on environmental factors such as temperature, moisture, and the present RF 
voltage – it must be scanned or set to change over time in order to do broad analysis.48, 75, 
78 However, the uniqueness of correct compensation voltage for a given analyte is so 
specific that even subtly different or isomeric species respond to different Cv values. This 
ability of FAIMS to discriminate even the smallest compositional differences will be 
discussed further and it is the reason such a technique is viable for glycopeptide analysis. 
3.7 Separation Based on Dipole Alignment  
 Though ion behavior through FAIMS is relatively understood at this point, it has 




presence of high and low electric fields and can thusly be separated from one another. As 
discussed before, ion behavior through FAIMS can be affected by temperature, moisture, 
pressure, and other environmental factors,48, 78 but these features are externally 
determined and have nothing to do with structure, composition, or innate character of an 
analyte. The relevant feature of ionic species that makes FAIMS separation possible is 
that of dipole alignment.  
 Fundamentally, all macroions have inherent dispersion of positive and negative 
charges resulting in permanent dipole moments with a given energy, p.80 Crudely 
approximating this dipole as having a positive and negative terminus, one could imagine 
that, in the presence of an electric field, a given macroion with its dipole will become 
specifically oriented – much like a compass in the presence of a magnetic field. 
Specifically pertaining to FAIMS, when the asymmetric radio frequency induces the high 
positive field, the dipole of ions experiencing this columbic force become materially 
aligned and orientationally “locked.”48, 80 Once the dipole of a macroion has been aligned 
in the presence of an electric field, the ability for the dipole to rotate becomes dependent 
on the rotational energy contained by the analyte, 𝜀𝑅, compared to the energy require to 
rotate the analyte in the presence of an electric field, A  – quantities for which can be 
defined as follows: 
 






𝐴 is energy 
𝜏 is torque in an electric field 
𝜑 is angle with respect to field vector 





𝐸 is electric field 
 𝜀𝑅 = 𝑘𝐵𝑇𝑅 (2.16) 
where  
𝜀𝑅 is the rotational energy 
𝑘𝐵 is the Boltzmann constant 
𝑇𝑅 is the temperature of rotation 
 
When the rotational energy available to an ion exceeds that of the energy required to 
rotate a dipole, rotation occurs freely and without consequence. However, as A increases 
– making the value of 𝜀𝑅/𝐴 smaller – the dipole becomes progressively more fixed in its 
orientation. When pictured spatially (figure 3.9), one could equate the relative alignment 
of dipole vectors as moving from a relatively freely-rotating state to that of a more 
confined, tight pendulum.48 
With this concept in mind, it is now plainly seen that as field intensity, E, 
decreases, the possibility of an ion rotating freely in space becomes greater. Logically, 
the average cross section, Ω, of an aspherical ion that rotates freely in space will be greater 
than the Ω of the same ion that is locked into a defined orientation80 and will therefore 
allow a greater number of collisions between the diffusing and carrier gas molecules. All 
in all, the difference in mobility between compositionally different analytes comes 
through the combination of having unique dipole alignment and steric connectivity that 
lead to unique Ω values in both the high and low fields, thusly affecting the mobility 
exhibited for each. 
3.8 Applications of FAIMS and Relevance to Glycopeptide Analysis 
 Due to its unique filtering and separation functionalities, FAIMS has been proven 




biomolecule analyses. Like the accomplishments of IMS mentioned previously, any but 
the most in-depth retelling of FAIMS studies would be inappropriate and the absence of 
such discussion indicates the breadth with which differential ion mobility has been 
applied. Briefly, FAIMS has shown the ability to separate peptide sequence isomers,81 
cis-trans isomers,82 lipids,83 identical peptides that vary only in the site of modification51-
52, 84-87 and many others. Though the changes in analytes may be quite small, it has been 
shown time and time again that FAIMS can provide more-than-adequate resolution for 
even isomeric species, indicating an obvious capability to separate compositionally 
different ions. Remembering the breadth of variation found when examining the biology 
of glycan moieties and understanding that the differences in the deposited modifications 
on protein conjugates could be obvious or extremely subtle indicates that FAIMS may be 
an excellent method for such PTM studies.  
 Though speculation alone indicates FAIMS would provide information useful for 
glycopeptide analysis, doing so without examining previous studies would be premature. 
This truth notwithstanding, there exist very few studies specifically dealing with bottom-
up analysis of glycoproteins combined with FAIMS. Work done by Helen Cooper, a 
prominent figure in ion mobility research, has demonstrated site-variable glycopeptides 
can be resolved through FAIMS8 – work that led to comprehensive glycosylation 
mapping of the flagellin on a bacterial species.88 This work demonstrates the principle of 
FAIMS is certainly suited to glycopeptide analysis, but modification mapping could 
potentially be accomplished through combining other chemistry techniques, making 
FAIMS unnecessary. However, these previous studies all but ignore the assessment of 




separations underutilized. For this reason, it becomes reasonable to investigate the ability 
of FAIMS to analyze unique glycoforms at the peptide level.   
3.9 Conclusion and Relevance to Current Work 
The introductory chapters of this thesis should serve to convey the difficulties and 
importance of glycoform analysis as well as the benefits of incorporating differential ion 
mobility into a proteomic workflow. In review, the diversity and biological significance 
of the present glycoforms for a given protein conjugate has been established, the desire 
to pursue bottom-up glycopeptide analysis has been determined, and the benefits of gas-
phase differential ion mobility analysis orthogonal to LC have been declared. The 
aggregate of these considerations leads to the method conceived in the following chapter. 
The project described below is built around flexibility and universal application for all 
sample types, finding a tunable and unbiased source of glycopeptide identification, and 
accurate separation and deepened understanding of present glycoforms. Effective 
implementation of these endeavors has been accomplished through the successful 
conception, creation, optimization, and validation of a novel LC-MS-FAIMS 








Figure 3.1 Schematic of IMS Drift Region  
Depiction of the drift region for traditional, drift-tube ion mobility spectrometers 
displaying the introduction of ion swarms and the difference in mobility between smaller 
(green) and larger (blue) analytes as ion-gas collisions take place.57 Figure reprinted with 
permission from Cumeras, R., et al. (2015). "Review on Ion Mobility Spectrometry. Part 
1: Current Instrumentation." The Analyst 140(5): 1376-1390. 2015. Royal Society of 



















Figure 3.2 Paschen Curves for Pure Gases 
Paschen curves of various pure gases that display the pressure of each that must be present 
in order to prevent breakdown of an electrical field at various strengths.58 Figure 













Figure 3.3 Gas Radius versus Ion Radius 
Pictorial representation of the influence of gas radius on diffusing molecules where small 
(dark circles) and large (grey circles) gas molecules of arbitrary radius, 𝑟𝑔, collide with 








Figure 3.4 Schematic of Trapped Ion Mobility Principle 
Schematic of TIMS device that demonstrates three stages of analysis. 1) Filling involves 
the introduction of ion swarms to the drift region – depicted here as three molecules with 
unique CCS, Ω, values that are inversely proportional to mobility, K. 2) Ions are separated 
by the carrier gas in accordance with their size-to-charge ratio. Ions will proceed through 
the mobility region until the electric field force is equivalent to the force applied by the 
carrier gas, reaching a “trapped” state. 3) Decreasing the electric field will allow ions to 
elute from high to low size-to-charge ratio.76 Reprinted with permission from Fernandez-
Lima, F., et al. (2011). "Gas-phase separation using a trapped ion mobility 
spectrometer." International Journal for Ion Mobility Spectrometry 14(2): 93-98. 2011. 









Figure 3.5 Traveling Wave Ion Mobility 
A sketch of the working principle of TWIMS. Ions (black circle) are supported in the 
presence of an electric field and advanced toward the detector by a series sequential, 
uniform potential waves administered through the separation region – forcing ions to 
migrate based on their mobility. The traveling waves cause smaller ions to migrate faster 
than larger.75 Reprinted with permission from Shvartsburg, A. A. and R. D. Smith (2008). 
"Fundamentals of Traveling Wave Ion Mobility Spectrometry." Analytical chemistry 









Figure 3.6 Schematic of Differential Mobility Analyzer 
Pictorial representation of the analyzing region of differential mobility analyzers. Ions 
are introduced (top left) between planar electrodes in the presence of an electric field (E) 
acting in line with the angle of introduction and a sheath flow (Qsheath) acting 90° to the 
same angle. Depending on ion characteristics and the electric field applied, only the 
analytes whose vector results in displacement equal to the distance L will be detected. 
The applied electric field is set to change over time and therefore selects for different 
species.77 Reprinted with permission from de la Mora Juan, F., et al. (2006). "The 
potential of differential mobility analysis coupled to MS for the study of very large singly 
and multiply charged proteins and protein complexes in the gas phase." Biotechnology 








Figure 3.7 Asymmetric Waveform as Applied to FAIMS 
Pictorial representation of the asymmetric RF voltages applied to FAIMS planar 
electrodes. Using otherwise random values, the high field operates at +4000V for a time 
of 0.4µs and the low field operates at negative one-half the high voltage, -2000V, for a 
time of 0.8µs. The resulting area under these curves is therefore equal in magnitude but 
opposite in polarity. As seen in the lower half of the figure, ionic species between the 
electrode will exhibit corresponding movement towards one electrode and then the other, 
being displaced along the y-axis according to the favored field.79 Reprinted with 
permission from Guevremont, R. (2004). "High-field asymmetric waveform ion mobility 
spectrometry: A new tool for mass spectrometry." Journal of Chromatography A 1058(1-








Figure 3.8 Compensation Voltage for Ion Path Correction 
A schematic of the non-zero average migration of ions through FAIMS planar electrodes. 
Ions (grey circle) are introduced at the beginning of the separation region and are 
subjected to the asymmetric RF voltage that induces both high and low fields operating 
for times t1 and t2, respectively. Depending on ion characteristics, analytes could exhibit 
a greater response to either field and the average migration from center is denoted as α<0 
for ions that respond to low fields and α>0 for ions responding to high fields. Only ions 
with α=0 will be detected, and, therefore, a compensation voltage may be superimposed 
over the RF dispersion voltage to correct an ion’s migration toward the center of the 
electrodes.78 Reprinted with permission from Borsdorf, H. and G. A. Eiceman (2006). 
"Ion Mobility Spectrometry: Principles and Applications." Applied Spectroscopy Reviews 






Figure 3.9 Dipole Alignments with Respect to Rotational Energy 
Pictorial representation of the various dipole alignment states of an ion in the presence of 
electric field. At low field strengths, the rotational energy (εr) of an ion is far greater than 
the energy required to rotate the dipole (A) and will rotate freely (a). As field strength 
increases and the value of εr/A becomes smaller, the ion will gradually be confined to 





Chapter 4: N-Linked Glycopeptide Feature Characterization Through 
FAIMS-Coupled Concurrent LC-MS Platform 
4.1 Abstract 
The extent of biologically and clinically relevant connections drawn to 
glycoproteins provide the separation, analysis, and characterization of these conjugates 
significant importance in the field of proteomics. However, the heterogeneity of 
glycoforms present for a protein makes separation and analysis quite challenging. 
Realizing the benefits of bottom-up investigation, the need for universal enrichment and 
separation methods, and the separating and analyzing power of gas-phase techniques, 
described here is a novel, three-dimensional glycopeptide workflow. Online monitoring 
of oxonium ions coupled to reverse-phase liquid chromatography allows for identification 
and enrichment of glycopeptides that may then be introduced to gas-phase ion mobility 
analysis for increased glycoform distinction. Our study shows the incorporation of 
differential ion mobility is useful for glycoform separation and may be used to assign 
glycopeptide features based on gas-phase ion behavior.  
4.2 Introduction 
In recent years, emphasis on proteomic studies have steadily increased in 
importance and significance across all sectors and fields of study. Due to the desire for 
increased comprehension of biological systems and how protein modification inspires or 
inhibits disease,89-91 understanding the diversity present within the proteome is necessary 




endeavors, it has been repeatedly demonstrated – and can now be considered fundamental 
– that a single gene is the precursor for not one but many proteins. This diversity in gene 
products is largely due to the inherent potential for post-translational modification (PTM) 
of all proteins, each unique set of modifications producing an equally unique 
proteoform.92  
PTMs (methylation, phosphorylation, acetylation, etc.) are a diverse set of 
molecules, enzymatically deposited on conjugate proteins at different points along the 
maturation process, that reversibly or irreversibly alter protein structure and function.89 
Though a PTM may be present on a given protein in many locations, and multiple 
different modifications may be expressed on the same protein simultaneously, a saving 
grace to proteomics studies is that many PTMs are not diverse in their structure (i.e. all 
methyl groups are the same and all phosphoryl groups have the same structure). For this 
reason, proteomic studies of an individual PTM can be highly specific and optimized for 
a given sample to discover both the number of proteoforms present and the location of 
present PTMs along a protein backbone. Glycosylation, however, is a PTM that dwarfs 
others in terms of complexity and biological significance.  
Glycosylation is one of few PTMs that exists as oligomers of its composing 
substituents – these oligomers are referred to throughout as glycans.1 The diversity of 
glycans found on any modification site is substantial – a phenomenon known as 
microheterogeneity – and can only be remotely understood if the differences are grouped 
into three broad categories: modification site, composition, and structure. With respect to 
modification site, all commonly occurring modifications can be classified as either O- or 




hydroxyl group of Serine and Threonine, whereas N-linked glycans are attached only to 
Asparagine residues that exist in the peptide motif of Asn-X-Thr, where X may be 
anything but Proline.1, 8, 18, 93 Furthermore, within the six classes of monosaccharides 
present in glycans (e.g. hexoses, pentoses, etc.) there have been reports of more than 70 
unique sugar residues that may be incorporated into a glycan chain. However, there are 
only 12 monosaccharides commonly present in these modifications, still leading to a 
significant level of diversity. Finally, in regard to glycan structure, the glycosidic bonds 
that link monosaccharides together can be in either α or β confirmation and may be 
formed between the reducing end of one sugar and any hydroxide-containing carbon on 
the next.1 Understanding the variety found in the glycans expressed on a given protein 
leads one to question: how, and for what reason, adequate glycosylation study may be 
facilitated.  
Because it is well known that multiple glycans can exist at any modification site 
and that multiple modification sites can be present on any given protein, accurate 
separation and determination of individual glycoforms is quite difficult but is of 
significant value due to the broad number of connections drawn between glycosylation 
and organism function, disease, and response.1, 94 Enzymatic release of glycans would 
allow for in-depth characterization of all present modifications but would lose all site-
specific information, whereas top-down analysis could only elucidate the number of 
glycoforms expressed and provide no relevant glycan structure information. Therefore, 
intact glycopeptides are a prime candidate for glycoform analysis, as examining intact 





Common glycopeptide analysis workflows (LC-MS and others), however, are often 
marked by significant limitations. Glycoproteins are quite diverse in character, level of 
modification, and level of expression, resulting in the current lack of a universal 
separation method. Also, the low abundance of glycopeptides compared to others from 
the same proteolytic activity necessitates the addition of an enrichment component, 
making studies more intricate. And additionally, the heterogeneity of glycoforms makes 
the separation of complex glycopeptide mixtures challenging, if not unfeasible. It has 
been noted that the implementation of a gas-phase separation component may benefit 
glycopeptide analysis – an idea that has been successfully proven in traditional ion 
mobility studies.7, 18, 43, 56, 69-71, 95 However, there exist few glycopeptide studies that utilize 
high-field asymmetric-waveform ion mobility (FAIMS) as the gas-phase separation 
component. Though not as useful for broad analysis,48, 78 the benefits of FAIMS are seen 
in its targeted detection and ion filtering capabilities,48, 78 tunability of gas composition, 
waveform, and compensation voltage, its smaller, simpler design78 that allows it to be 
installed on existing MS instruments, and separation based on dipole alignment that 
results in good orthogonality to LC and MS.  
Considering the need for a universally applicable method of glycopeptide analysis, 
reported here is an unbiased, RPLC-MS glycopeptide enrichment method coupled to 
differential ion mobility. Being one of few glycopeptide studies integrated with FAIMS, 
this method demonstrates that gas-phase analyte behavior can be used to reveal 
glycopeptide features, distinguish between modified and unmodified peptides, and 




4.3 Experimental  
4.3.1 Materials 
The standard protein Ribonuclease B (RNaseB), internal peptide standard Syntide 
2 (Syn2), Ammonium bicarbonate (ABC), Urea, 1,4-Dithiothreitol (DTT), 
Iodoacetamide (IAA), TPCK Trypsin, and Acetonitrile (ACN) were all purchased from 
Sigma-Aldrich (Milwaukee, WI, USA). Ammonium bicarbonate solution was prepared 
at a concentration of 25mM; aliquots of this stock solution were used to prepare reducing 
(DTT) and alkylating (IAA) agents and Trypsin at concentrations of 200mM, 200mM 
and 1 mg/mL, respectively. Formic Acid and BCA protein assay kits were purchased 
from ThermoFisher (Hanover Park, IL, USA). 
4.3.2 Trypsin Digestion 
Prior to digestion, ~1 mg Standard protein was reconstituted in 10 µL of 25mM 
ABC and denatured at room temperature by a single 100 µL aliquot of 6M Urea with 
minimal mixing. Immediately following denaturation, 5 µL of DTT solution was 
introduced to the mixture, vortexed, and allowed to reduce at 37°C for 1 hour. 20 µL IAA 
was then added to the mixture and left to react in complete darkness at room temperature 
for 1 hour. Upon completion, 20 µL of DTT was added to deactivate any remaining IAA, 
followed by the addition of 900 µL ABC solution to dilute the remaining urea. Trypsin 
was introduced to the mixture in a 1:30 (enzyme:protein) ratio, w:w, and left to react at 





Following digestion, samples were desalted and concentrated to a final volume of 
~1.5mg/mL according to BCA concentration measurements. 125 µL sample aliquots 
were injected on an Agilent C18 column (2.1x150mm, dp=1.8µm) using a Thermo 
autosampler, pump, PDA detector setup. Using ultrapure H2O+0.1% FA and ACN+0.1% 
FA as buffers A and B, respectively, samples were introduced at 97% A for 20 minutes 
and fully eluted on a 25-minute gradient to 97%B. Elutions were split on a T-junction 
between a Thermo LTQ Orbitrap Velos Pro with a custom nano-electrospray (ESI) 
interface and an Advion Triversa Nanomate, such that the bulk flow was sent for fraction 
collection. Capillary temperature was set to 275°C with a spray voltage of 2.6 kV. Full 
MS spectra were collected at a resolution of 60,000 with an m/z range of 350-2000. Data-
dependent MS/MS collisional fragmentation data was collected using high-energy 
collisional dissociation (HCD) at an energy of 30. 
4.3.4 Oxonium Ion Monitoring 
Oxonium ions are singly-charged fragments of the glycan chains resulting from 
collisional dissociation methods. Oxonium ions and their associated masses are 
characteristic of glycopeptides and therefore can be used to identify when such analytes 
are eluted and have reached the detector.96 Evaluating MS2-level data allowed for online 




4.3.5 Concurrent Fractionation via Triversa Nanomate 
Fraction collection parameters were set through the Advion ChipSoft program 
interface such that fractions were collected at a time interval of 60 seconds and deposited 
into a 96-well PCR Plate. The Nanomate fraction collection and MS analysis were 
manually started simultaneously to ensure accurate correlation between MS and 
fractionation timepoints. Temperature control was set to 4°C to avoid any extensive 
drying of highly-organic fractions.  
4.3.6 FAIMS Instrumentation and Method 
Maintaining previously reported instrumental methods, FAIMS analysis was 
conducted using planar electrodes with a gap width of 1.88 mm and a length of ~50 mm 
mounted to a Thermo LTQ XL ion trap.51 The asymmetric waveform, with harmonics in 
a 2:1 ratio, and dispersion voltage (DV) were provided by a generator purchased from 
Heartland Mobility. The ESI emitter voltage was set to ~3 kV above the curtain plate 
FAIMS inlet.51 Carrier gas compositions in all trials were optimized mixtures of N2 and 
He formulated from UHP components by digital flow meters (MKS Instruments, 
Andover, MA, USA), purified by an Agilent filter, and delivered at a flow rate of 2 L/min. 
All fractions collected for FAIMS analysis were lightly concentrated and combined with 
ACN+0.1% FA for direct infusion (50:50 sample to buffer ratio). Sample flow rate was 
set to 0.3 µL/min while compensation voltage ranges and rates were determined as 





4.4.1 Digestion and Glycopeptide Separation Analysis 
RNaseB, containing a single high-mannose glycan located on Asparagine34, has 
been extensively studied and repeatedly characterized,10, 18, 43 making it a prime candidate 
for validation of this method. Trypsin digestion of RNaseB in preliminary trials yielded 
the base peptide of N34LTK with five definitively resolved glycan modifications, 
GlcNAc2Man5-9 (figure 4.2); glycopeptide elution was confirmed through the MS
2 
presence of fragmented hexosamine residues (figure 4.3). Due to the dominating 
hydrophilic character of these glycopeptides, retention on C18 should be highly 
unfavorable, an inference that is confirmed by elution peak occurring prior to gradient 
introduction (figure 4.3). Comparison of the LC retention for each of the five glycoforms 
showed only slight deviation or broadening based on hydrophilic character (figure 4.4), 
necessitating further separation.  
4.4.2 FAIMS Separation of Base Peptide Glycoforms 
In accordance with predictions, FAIMS demonstrated accurate separation of all 5 
glycoforms at each tested gas composition, similar to the separation depicted at 60% He 
(figure 4.5). Notably, there was a linear correlation between the addition of one mannose 
residue and the compensation field (Ec) necessary to detect the analyte (figure 4.6). Such 
a trend indicates that the dipole alignment of glycopeptides is dominated by the glycan 
chain but will alter slightly with peptide backbone composition and FAIMS can, 




all tested gas compositions (40, 50, and 60% He) is depicted by plotting the Ec 
corresponding to the major peak values and shows a regular deviation of the Man6 
glycoform – an occurrence also noted by Glaskin, et al., that was attributed to a prevailing 
elongated glycan confirmation. Selecting the Man6 minor peak shows stronger correlation 
and linearity. The question then turns to differentiating between similar analytes when a 
single characteristic is changed (e.g. backbone, glycan, or presence/absence of 
modification). 
4.4.3 Optimized Digestion for Increased Glycoform Presence 
Having verified the three-dimensional glycopeptide enrichment and analysis 
method as viable, Trypsin digestion of RNaseB was performed in lowered 
enzyme:protein ratio to reduce digestion efficiency. Online monitoring of oxonium ions 
again displayed the pre-gradient elution corresponded to the elution of glycopeptides 
(figure 4.7). Summing the extract ion chromatography (EIC) region for these time points 
displayed the presence of 4 unique peptides each yielding 5 glycoforms (figure 4.8). In 
agreement with the preliminary trials, the complex mixture of 20 glycopeptides showed 
no discernable separation through the LC phase (figure 4.9); the corresponding fractions 
were collected for FAIMS analysis. Additionally, non-glycosylated peptides retained by 
the C18 column that eluted during the gradient were also kept for later comparison. The 
sample pool was adequate to provide analysis of FAIMS behavior for distinct groupings: 
glycopeptides of varying backbone with constant glycans, varying glycans with constant 




4.4.4 Feature Characterization Through FAIMS Behavior 
The peptides observed varied in length from 4 to 8 residues, each expressing 5 
glycan modifications (Man5-9). To evaluate behavior of these analytes through FAIMS, 
plots of Ec vs. m/z, were created for each base peptide (e.g. NMan5-9LTK, SRNMan5-9LTK, 
etc.). Comparison of the trends expressed for each peptide were unique and displayed the 
most significant difference between the longest and shortest base peptides, -0.078 to -
0.059, respectively (figure 4.10). The difference in trend between all four peptide 
backbones indicates that such features can be characterized by analyte behavior through 
FAIMS. Differentiating glycopeptides from RNaseB that varied by no more than 4 
residues is promising, as backbones with greater difference in composition will almost 
assuredly display even greater difference in FAIMS behavior. 
To determine if glycan composition can also be used to differentiate species in the 
gas phase, plots of Ec vs. m/z were formulated for each glycan chain (Man5-9) as the 
attached peptide changes. The trend expressed for each is again well-defined showing the 
greatest difference between the shortest (Man5) and longest (Man9) glycan chains. Similar 
to the results discriminating based on backbone, the high-mannose glycan chains 
analyzed here exhibit only small changes to one another when compared the vast number 
of glycans presented in the proteome. If compared to glycans of vastly different 
composition, greater distinction in analyte behavior through FAIMS would be apparent.  
4.4.5 Discrimination of Glycosylated and Non-Glycosylated Peptides 
Though specific features were successfully characterized based on trends in 




therefore, be grouped together and compared to analytes of different classification (figure 
4.11). Non-glycosylated peptides from the elution profile of RNaseB were identified 
using MS-GF+ (PNNL) and introduced to FAIMS (table 4.2). The dipole character of 
these non-glycosylated peptides should be greatly different from one another and exhibit 
very little correlation; this low correlation should, therefore, allow obvious discrimination 
from glycosylated peptides. Examination of non-glycosylated peptides against the 
original 20 glycopeptides studied showed not only a poorly correlated relationship of non-
glycosylated peptides, but also no discernable relation to the established glycopeptide 
trend (figure 4.12). Though some peptides with m/z in the same range as the 
glycopeptides may be detected at similar compensation field values – providing data 
points close in proximity – these instances would only arise if there was a complete lack 
of liquid-phase separation prior to FAIMS analysis.   
4.4.6 Altered Gas-Phase Confirmations for Higher Charge State Peptides 
The 8-resiude glycopeptide is the only analyte that demonstrated multiple charge 
states, 2+ and 3+, whereas the other glycopeptides were confined to the lower state due 
to their small backbone and suppressed ionization commonly occurring with 
glycopeptides. Through FAIMS, the 2+ charge state of the longest peptide displayed 
moderate peak broadening and shouldering – indicating the possible presence of multiple 
isomeric species. Though no meaningful separation was obtained, optimizing FAIMS 
parameters could lead to separation of any simultaneously detected species. However, at 
the higher charge state of 3+, there was immediate peak divergence with sufficient 




certainly could reveal the presence of isomeric species in accordance with previous IMS 
experiments,43 the nature of glycan chains suggest that charge will be located in the 
peptide backbone and the increase in charge state could, therefore, result in non-naturally 
occurring glycopeptide confirmations.18 Fragmentation analysis of the multiple peaks at 
charge state 3+ could lead to confirmation of either reality but routine commercial 
ionization techniques offer limited information for glycopeptides, indicating the need for 
further method consideration. 
4.5 Conclusion  
The online monitoring and concurrent fractionation method described has been 
proven successful for glycopeptide enrichment and can be further applied to a wide array 
of sample types due to the high accuracy resulting from oxonium ion monitoring. 
Analysis of analyte behavior through FAIMS has demonstrated that peptides can be 
differentiated based on subtle differences in peptide backbone and glycan composition 
while discrimination between glycopeptides and non-glycosylated peptides is easily 
obtained. FAIMS has also revealed that increased charge states could facilitate greater 
resolution of isomeric species, though more confirmation is needed. This three-
dimensional method is tunable at the LC, MS, and FAIMS levels and can therefore be 
optimized to accurately separate, analyze, and characterize features of glycopeptides from 
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Figure 4.1 RPLC-MS-FAIMS Platform 
The overall schematic of the platform utilized for glycopeptide identification and 
characterization. Digested glycoproteins are introduced to reverse-phase liquid 
chromatography coupled to mass spectrometry. As elution proceeds, the presence of 
oxonium ions is monitored, indicating the time points at which glycopeptides are eluted. 
Simultaneously, a Triversa Nanomate accurately deposits fractions in a 96-well plate 
format. The fractions corresponding to the detection of oxonium ions are then collected 





















Table 4.1 Compensation Voltage Scan Ranges 
Glycopeptides eluted across three fractions, as determined through online monitoring of 
oxonium ions. Each of the three fractions were unique in the peptides contained and their 
relative abundance, necessitating optimization of Cv scan range for each fraction. 
Furthermore, as He% increases, there is also a need to alter the Cv scan range to ensure 
accurate detection of all contained analytes. The Cv scan ranges listed were chosen 
through manual manipulation of Cv voltage and assessing the smallest range that allowed 







Figure 4.2 Mass Spectra of Summed Oxonium Ion Detection 
Summing the time frame for the early elutions with corresponding oxonium ions yields 5 
unique glycopeptides in the m/z range 846-1171. The glycan chains attached to the base 
peptide (N34LTK) are illustrated above each m/z value – N-Acetylglucosamine residues 
depicted by blue squares and Mannose residues depicted by green circles. Illustrated 






Figure 4.3 Preliminary RNaseB Chromatogram and MS2 Oxonium Ion Abundance 
Total ion chromatogram (a) for the initial reverse-phase chromatography separation of 
RNaseB subjected to tryptic digestion. The elutions appearing before the gradient began 
indicated the presence of low-binding peptides. Comparing the MS2 extract ion 
chromatogram for m/z=204.09 (b) shows the presence of oxonium ions corresponding to 






Figure 4.4 RPLC Retention of RNaseB Glycopeptides 
The LC retention of the 5 glycoforms for the base peptide, N34LTK, shown as a heat map 
with red indicating the most intense values. Being relatively uniform in composition, 
RPLC does not retain one glycoform more efficiently than another, making any 
differences in retention time or peak broadening due to the varying hydrophilic character 







Figure 4.5 FAIMS Separation of RNaseB Base Glycopeptides 
EIC for the 5 glycoforms of the base peptide through FAIMS filtering. Each glycoform 
responding to unique compensation fields indicates that FAIMS can be used as a 
separation component for glycopeptides. The linear trend demonstrated provides 
evidence that there is a connection between analyte composition or structure and behavior 







Figure 4.6 Compensation Field vs. m/z for RNaseB Base Peptides 
M/z values of each glycoform plotted against the Ec value at which the analyte is detected, 
demonstrating the linear trend in their behavior through FAIMS. The deviating value, 
m/z=927.38, corresponds to the GlcNAc2Man6 glycoform, which has been previously 
noted to have a dominant elongated glycan conformation.18 The data points plotted above 
were chosen by inserting the major peak values according to EIC and substituting the 
minor peak value for GlcNAc2Man6 increases the correlation of the linear trend. All 









Figure 4.7 TIC and MS2 Oxonium Ion Abundance for Optimized Digestion 
TIC (a) and MS2 extract ion chromatogram for m/z=204.09 (b) for the optimized 
digestion of RNaseB to inspire digestion inefficiency. Similar to the preliminary trials, 
the large elution prior to gradient corresponds to the presence of oxonium ions and 









Figure 4.8 Summed Mass Spectra of Multiple Glycopeptide Elution 
Summing the region corresponding to oxonium ion detection yields the base peptide 
(N34LTK), two peptides with one missed cleavage site (SRN34LTK, N34LTKDR), and the 
2+ and 3+ charge states of a peptide with two missed cleavage sites (SRN34LTKDR). 










Figure 4.9 RPLC Retention Heat Map for Complex Glycopeptide Mixture 
The complex mixture of glycopeptides plotted as a heat map of LC retention time. The 
extreme overlap and inconsistency of retention indicates that RPLC alone cannot be used 
as a separating component for these small glycopeptides from one another but can be used 








Figure 4.10 Ec vs. m/z for Shortest and Longest Peptide Backbone 
Comparison of linear trends exhibited by the shortest and longest glycopeptides at charge 
state 2+. The difference in trend indicates that backbone features may be assigned to an 
analyte based on its behavior through FAIMS, especially when considering glycopeptides 
from other proteins could be much longer in length and will be distinguished even further. 






Figure 4.11 Overall Trend in Ec vs. m/z for All Glycopeptides 
Plotted as Ec vs. m/z, the 20 glycopeptides of varying backbone and glycan feature 
demonstrate an overall trend after FAIMS analysis. This trend indicates that FAIMS 
behavior is more-than-likely dominated by the presence of a large glycan chain and will 
therefore allow discrimination of analytes containing these groups. All values plotted at 















653.32697 E.SLADVQAVC(+57.021)SQK.N 2 
755.39166 N.QMMKSRNLTKDR.C 2 
836.41473 F.VHESLADVQAVC(+57.021)SQK.N 2 
927.8861 D.SSTSAASSSNYC(+57.021)NQMMK.S 2 
1057.4916 K.C(+57.021)AVNKQSC(+57.021)VAQVDALSEHV.F 2 
1065.9364 G.QTNC+57.021YQSYSTM(+15.995)SITDC(+57.021)R.E 2 
1075.5173 R.ETGSSKYPNC(+57.021)AYKTTQANK.H 2 
1183.9784 R.QHMDSSTSAASSSNYC(+57.021)NQMMK.S 2 
 
Table 4.2 Non-Glycosylated Peptides Examined Through FAIMS 
MS-GF+ analysis of the RNaseB elution profile allowed for the determination of identity 
for all retained and unretained peptides detected by MS. To determine the ability of 
FAIMS to discriminate between modified and unmodified peptides, several peptides at 
charge state 2+ with a m/z value within or near the range of the examined glycopeptides 











Figure 4.12 Discrimination of Glycopeptides and Non-Glycosylated Peptides 
When examining m/z values that correspond to non-glycosylated peptides, not only does 
FAIMS analysis demonstrate a poorly correlated trend, but also clear distinction between 
modified and unmodified peptides. Increasing the number of non-glycosylated peptides 
analyzed through FAIMS will allow for a more well-defined trend. All values plotted at 











Figure 4.13 FAIMS Separation for Charge State Variants 
Examining the EIC of the 2+ and 3+ charge states for the longest glycopeptide reveals 
additional gas-phase conformations for those with greater charge. The diverging peaks 
present in the higher charge state display either increased FAIMS separation of naturally 
occurring isomers or the possibility that increasing charge state of small glycopeptides 
forces them into conformations not commonly occurring. FAIMS can be used to further 
analyze which case presents the truth, but careful fragmentation studies would be 
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